BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16316350)

  • 1. Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.
    Ballinger ML; Thomas MC; Nigro J; Ivey ME; Dilley RJ; Little PJ
    Kidney Int; 2005 Dec; 68(6):2756-65. PubMed ID: 16316350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end-products enhance calcification in vascular smooth muscle cells.
    Ren X; Shao H; Wei Q; Sun Z; Liu N
    J Int Med Res; 2009; 37(3):847-54. PubMed ID: 19589269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocynin decreases AGEs-induced stimulation of NF-κB protein expression in vascular smooth muscle cells from GK rats.
    Silva CO; da Silva OA; Duarte GP; Descomps B; Lahlou S
    Pharm Biol; 2015 Apr; 53(4):488-93. PubMed ID: 25471209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products accelerate arteriosclerosis after renal transplantation through the AGE/RAGE/ILK pathway.
    Liu X; Liu K; Wang Z; Liu C; Han Z; Tao J; Lu P; Wang J; Wu B; Huang Z; Yin C; Gu M; Tan R
    Exp Mol Pathol; 2015 Oct; 99(2):312-9. PubMed ID: 26210487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
    Boulanger E; Wautier MP; Wautier JL; Boval B; Panis Y; Wernert N; Danze PM; Dequiedt P
    Kidney Int; 2002 Jan; 61(1):148-56. PubMed ID: 11786095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
    Ivey ME; Little PJ
    Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats.
    de Oliveira Silva C; Delbosc S; Araïs C; Monnier L; Cristol JP; Pares-Herbute N
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):23-30. PubMed ID: 17127041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.
    Lohwasser C; Neureiter D; Weigle B; Kirchner T; Schuppan D
    J Invest Dermatol; 2006 Feb; 126(2):291-9. PubMed ID: 16374460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.
    Zhong Y; Li SH; Liu SM; Szmitko PE; He XQ; Fedak PW; Verma S
    Hypertension; 2006 Sep; 48(3):504-11. PubMed ID: 16847147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium.
    Nam MH; Son WR; Lee YS; Lee KW
    Cell Commun Adhes; 2015; 22(2-6):67-78. PubMed ID: 27602595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation.
    Boulanger E; Grossin N; Wautier MP; Taamma R; Wautier JL
    Kidney Int; 2007 Jan; 71(2):126-33. PubMed ID: 17149374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Na+/H+ exchanger 1 in advanced glycation end products-induced proliferation of vascular smooth muscle cell.
    Wu S; Song T; Zhou S; Liu Y; Chen G; Huang N; Liu L
    Biochem Biophys Res Commun; 2008 Oct; 375(3):384-9. PubMed ID: 18703017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs.
    Lieuw-a-Fa ML; Schalkwijk CG; Engelse M; van Hinsbergh VW
    Thromb Haemost; 2006 Feb; 95(2):320-8. PubMed ID: 16493495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.
    Sun M; Yokoyama M; Ishiwata T; Asano G
    Int J Exp Pathol; 1998 Aug; 79(4):207-22. PubMed ID: 9797717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis.
    Ping S; Li Y; Liu S; Zhang Z; Wang J; Zhou Y; Liu K; Huang J; Chen D; Wang J; Li C
    PLoS One; 2015; 10(10):e0141375. PubMed ID: 26488175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.
    Li JH; Wang W; Huang XR; Oldfield M; Schmidt AM; Cooper ME; Lan HY
    Am J Pathol; 2004 Apr; 164(4):1389-97. PubMed ID: 15039226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein binding.
    Hashimura K; Sudhir K; Nigro J; Ling S; Williams MR; Komesaroff PA; Little PJ
    Endocrinology; 2005 Apr; 146(4):2085-90. PubMed ID: 15661861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.